Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

cGMP in 2026: Inspection Expectations and Compliance Gaps

This article explores key FDA inspection priorities in pharmaceutical manufacturing, focusing on data integrity controls, CAPA effectiveness, audit trail review, and common quality system failures. It also explains how companies can reduce regulatory risks and improve compliance readiness.
  • Blog, Quality Management System
Infographic showing FDA inspection priorities including data integrity controls, CAPA effectiveness, audit trail review, GMP compliance checklist elements, and common pharmaceutical quality system failures in regulatory inspections.

GMP Audit in 2026: Inspection Readiness and Control Gaps

This article explains how GMP audits evaluate inspection readiness through structured checklists, data integrity controls, CAPA effectiveness, and audit trail reviews. It highlights common findings, root causes, and how quality systems can improve compliance performance and inspection outcomes.
  • Blog, Quality Management System
GMP compliance checklist infographic showing inspection readiness elements, data integrity audit controls, CAPA effectiveness tracking, and audit trail review processes in pharmaceutical quality systems.

Cleaning Validation in Pharma for Inspection Readiness in 2026

This article breaks down the practical steps for cleaning validation protocol pharma, from defining acceptance criteria and worst-case scenarios to swab and rinse sampling. Learn how to reduce inspection findings and ensure GMP-compliant equipment cleaning validation lifecycle.
  • Blog, Validation and Qualification
Infographic showing pharmaceutical cleaning validation protocol, sampling strategies, and residue control methods in a GMP-compliant manufacturing environment.

Pharmaceutical Water System Validation for GMP Compliance in 2026

Explore how pharmaceutical water system validation safeguards product quality and prevents microbial contamination. This article highlights best practices for monitoring, sanitization, and sampling plans, ensuring compliance with GMP standards and minimizing risks identified during regulatory inspections
  • Blog, Validation and Qualification
Pharma water system qualification and water for injection validation with proper sampling and contamination control framework.

Concurrent Validation in Pharma: Compliance and Inspection in 2026

Explore how concurrent validation in pharma ensures real-time process reliability, strengthens GMP compliance, supports accurate documentation traceability, and minimizes FDA inspection risks, helping pharmaceutical teams maintain consistent batch quality and robust operational controls.
  • Blog, Validation and Qualification
Pharmaceutical lab team conducting process validation in pharma, monitoring batch release standards, documentation traceability, and adherence to validation protocols.

Key Differences Between GMP VS GLP Standards in Pharma in 2026

Explore this article to understand how GMP compliance and GLP compliance shape pharmaceutical operations. Learn about inspection drivers, lab quality controls, process validation, and cross-functional coordination to reduce risks and strengthen regulatory adherence in manufacturing and lab environments.
  • Blog, GMP
Pharma operations showing GMP inspection checklist, GLP protocol adherence, lab quality control, and documentation traceability in a compliant manufacturing and lab setup.

European Good Manufacturing Practices: Key Inspection Focus Areas in 2026

European GMP inspections increasingly focus on data integrity, documentation control, and quality systems. This article explores key EMA inspection areas, common compliance gaps, and practical strategies pharmaceutical manufacturers can implement to improve inspection readiness and strengthen overall EU GMP compliance
  • Blog, Validation and Qualification
Pharmaceutical manufacturing facility demonstrating EU GMP documentation control, EU data integrity rules, and quality system requirements during EMA inspection findings review.

FDA good manufacturing practices in 2026: inspection requirements explained

This article explores key FDA GMP requirements and strategies for maintaining proper GMP documentation control. Reading it helps pharmaceutical teams prepare for inspections while reducing the risk of Form 483 observations and other compliance issues.
  • Blog, Quality Management System
QA specialists reviewing FDA GMP compliance checklist and assessing GMP data integrity expectations on a pharmaceutical production line.

WHO GMP Inspection Expectations for Pharmaceutical Manufacturers in 2026

WHO GMP inspection expectations define how pharmaceutical manufacturers manage quality systems, documentation, and compliance processes. This article explores inspection priorities, common findings, and practical strategies to align operations with global GMP inspection standards and ensure continuous regulatory readiness.
  • Blog, Quality Management System
Infographic presenting WHO GMP certification and compliance requirements including validation, internal audits, and pharmaceutical quality systems WHO aligned with global inspection standards.

Change Control in Pharma-GMP Oversight Teams in 2026

Effective change control in the pharmaceutical industry requires structured evaluation, strong documentation, and proactive risk management. This article explores key inspection findings, root causes, and practical strategies to strengthen compliance and maintain continuous GMP inspection readiness.
  • Blog, Quality Management System
Pharmaceutical team reviewing change control processes highlighting GMP change control requirements and quality risk management in pharma changes